Special items: Ovarian Cancer and Us blog best viewed in Firefox

Sunday, January 10, 2010

(repost): Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity : BMJ

abstract only - BMJ does not have open access (pay per view/subscription req'd)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.